Schnitzler syndrome: Case report, the experience with glucocorticoid and anakinra (Kineret™) therapies and monitoring of systemic cytokine response;Schnitzler-syndrom: Popis případu, zkušenosti s léčbou glukokortikoidy a preparátem anakinra (Kineret™) a sledování cytokinové odpovědi organizmu

Vnitrni Lekarstvi

Volumn 57, Issue 1, 2011, Pages 97-112

  Szturz, Petr ^a   Adam, Z ^a   Klabusay, M ^a   Fojtik Z ^a   Kadanka Z ^a   Stehlikova O ^a   Chovancova J ^b   Kalvodova L ^a   Corbova D ^a   Stary K ^a   Neubauer, J ^a   Prasek J ^a   Koukalova R ^c   Rehak Z ^c   Hajek R ^a   Mayer, J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c Gastroenterologickéodd lení Masarykova Onkologického Ústavu Brno   (Czech Republic)

Author keywords

Autoinflammatory diseases; Cushing's syndrome; Interleukins; Monoclonal gammopathy; Multiple myeloma; Schnitzler syndrome

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; IMMUNOGLOBULIN M; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; PYROPHOSPHATE TECHNETIUM TC 99M; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; ANTIRHEUMATIC AGENT; CYTOKINE; GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTHRALGIA; ARTICLE; BIOLOGICAL THERAPY; BLOOD EXAMINATION; BONE PAIN; BONE SCINTISCANNING; CASE REPORT; CHILL; CLAVICLE; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL BONE; CORTICOSTEROID THERAPY; CUSHING SYNDROME; CYTOKINE RESPONSE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG TOLERANCE; ERYTHROCYTE SEDIMENTATION RATE; FEVER; FOLLOW UP; GAMMOPATHY; HUMAN; HYPEROSTOSIS; IMMUNOGLOBULIN BLOOD LEVEL; KNEE PAIN; LEG; LEUKOCYTE; LONG BONE; MALE; PATIENT MONITORING; PELVIC GIRDLE; PROTEIN BLOOD LEVEL; SACRUM; SCHNITZLER SYNDROME; THICKNESS; THORAX; TIBIA; URTICARIA; BLOOD; MIDDLE AGED;

ANTIRHEUMATIC AGENTS; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; SCHNITZLER SYNDROME;

EID: 79951784677     PISSN: 0042773X     EISSN: 18017592     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Schnitzler L, Schubert B, Boasson M et al. Urticaire chronique lesions osseuses macroglobulinémie IgM: Maladie de Waldenström? Bull Soc Fr Dermatol Syph 1974; 81: 363-366.
2. Lipsker D, Veran Y, Grunenberger F et al. The Schnitzler syndrome: four new cases and review of the literature. Medicine (Baltimore) 2001; 80: 37-44. (Pubitemid 32066377)
3. Besada E, Nossent H. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clin Rheumatol 2010; 29: 567-571.
4. Klener P et al. Cytokiny ve vnitřním lékař ství. Praha: Grada Publishing 1997.
5. Kluger N, Bessis D, Guillot B. Tocilizumab as a potential treatment in Schnitzler syndrome. Med Hypotheses 2009; 72: 479-480.
6. Hochberg Z, Pacak K, Chrousos GP. Endocrine withdrawal syndromes. Endocr Rev 2003; 24: 523-538.
7. Marek J. Léčba kortikoidy. Doporučené postupy. Projekt MZ ČR zpracovaný ČLS JEP za podpory grantu IGA MZ ČR 5390-3. Praha: ČLS JEP 2002.
8. Brunová J, Bruna J. Klinická endokrinologie a zobrazovací diagnostika endokrinopatií. Praha: Maxdorf 2009.
9. Martinez-Taboada VM, Fontalba A, Blanco R et al. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum 2005; 52: 2226-2227. (Pubitemid 40994347)
10. Loock J, Lamprecht P, Timmann C et al. Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome. J Allergy Clin Immunol 2010; 125: 500-502.
11. Pizzirani C, Falzoni S, Govoni M et al. Dysfunctional inflammasome in Schnitzler's syndrome. Rheumatology (Oxford) 2009; 48: 1304-1308.
12. Asahina A, Sakurai N, Suzuki Y et al. Schnitzler's syndrome with prominent neutrophil infiltration misdiagnosed as Sweet's syndrome: a typical example of urticarial neutrophilic dermatosis. Clin Exp Dermatol 2010; 35: e123-e126.
13. Migliorini P, Del Corso I, Tommasi C et al. Free circulating interleukin-18 is increased in Schnitzler syndrome: a new autoinflammatory disease? Eur Cytokine Netw 2009; 20: 108-111.
14. Tomková H, Shirafuji Y, Arata J. Schnitzler's syndrome versus adult onset Still's disease. Eur J Dermatol 1998; 8: 118-121. (Pubitemid 28149846)
15. SanMartín O, Febrer I, Botella R et al. Urticarial lesions and monoclonal IgM gammopathy. Schnitzler's syndrome. Arch Dermatol 1994; 130: 1193-1198.
16. Almerigogna F, Giudizi MG, Cappelli F et al. Schnitzler's syndrome: what's new? J Eur Acad Dermatol Venereol 2002; 16: 214-219.
17. Kropp JD, Czarnetzki BM. Urticaria - vasculitis und Schnitzler's syndrome. Allergologie 1994; 17: S17-S20.
18. Berdy SS, Bloch KJ. Schnitzler's syndrome: a broader clinical spectrum. J Allergy Clin Immunol 1991; 87: 849-854.
19. Borradori L, Rybojad M, Puissant A et al. Urticarial vasculitis associated with monoclonal IgM gammopathy, Schnitzler's syndrome. Brit J Dermatol 1990; 123: 113-118. (Pubitemid 20226523)
20. Morita A, Sakakibara S, Yokota M et al. A case of urticarial vasculitis associated with macroglobulinemia (Schnitzler's syndrome). J Dermatol 1995; 22: 32-35.
21. Lautenschlager S, Itin PH. Schnitzler's syndrome. Hautarzt 1993; 44: 781-784.
22. Janier M, Bonvalet D, Blanc MF et al. Chronic urticaria and macroglobulinemia (Schnitzler's syndrome): report of two cases. J Am Acad Dermatol 1989; 20: 206-211. (Pubitemid 19055626)
23. Olsen E, Førre O, Lea T et al. Unique antigenic determinants used as markers in a patient with macroglobulinemia urticaria. Similar idiotypes demonstrated in the skin and on peripheral blood lymphocytes. Acta Med Scand 1980; 207: 379-384.
24. de Koning HD, Bodar EJ, van der Meer JW et al. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 2007; 37: 137-148. (Pubitemid 350151505)
25. de Koning HD, van der Meer JW, Simon A. Comment on: Schnitzler's syndrome exacerbation after anti-TNF treatment. Rheumatology (Oxford) 2007; 46: 1741. (Pubitemid 350018503)
26. Ščudla V, Adam Z, Ščudlová M. Současné možnosti diagnostiky a léčby anémie chronických chorob. Vnitř Lék 2001; 47: 400-406.
27. Lecompte M, Blais G, Bisson G et al. Schnitzler's syndrome. Skeletal Radiol 1998; 27: 294-296. (Pubitemid 28254202)
28. De Saint-Pierre V, Ehrhart A, Baron D et al. Systemic urticaria, sclerosing osteopathy, monoclonal gammopathy (Schnitzler's syndrome). Apropos of a case. Rev Rhum Mal Osteoartic 1992; 59: 288-292.
29. De Waele S, Lecouvet FE, Malghem J et al. Schnitzler's syndrome: an unusual cause of bone pain with suggestive imaging features. AJR Am J Roentgenol 2000; 175: 1325-1327.
30. Flórez AF, Gallardo Agromayor E, García-Barredo R et al. Radiological aid to clinical diagnosis of Schnizler's syndrome: multimodality imaging approach. Clin Rheumatol 2008; 27: 107-110.
31. Ferrando FJ, Pujol J, Hortells JL et al. Schnitzler's syndrome: report of a case with bone osteolysis.J Investig Allergol Clin Immunol 1994; 4: 203-205.
32. Bertrand A, Feydy A, Belmatoug N et al. Schnitzler's syndrome: 3-year radiological follow-up. Skeletal Radiol 2007; 36: 153-156.
33. Dupuy O, Pinede L, Coppere B et al. Schnitzler's syndrome with stable course over a 18-year period. Report of a case. Presse Med 1995; 24: 1402.
34. Adam Z, Krejčí M, Vorlíček J. Maligní krevní nemoci. Praha: Grada Publishing 2008.
35. Adam Z. Diferenciální diagnostika monokloná lních gamapatií. Intern Med pro Prax 2004; 5: 279-283.
36. Šedivá A. Poruchy regulace zánětu a periodické horečky. Alergie 2006; 1: 36-41.
37. Adam Z, Šmardová J, Ščudla V. Waldenströmova makroglobulinemie - klinické projevy, diferenciálnǐ diagnostika a prognóza nemoci. Vnitř Lék 2007; 53: 1325-1337.
38. Pujol RM, Barnadas MA, Brunet S et al. Urticarial dermatosis associated with Waldenström's macroglobulinemia. J Am Acad Dermatol 1989; 20: 855-857. (Pubitemid 19127930)
39. Lipsker D, Cribier B, Maloisel F et al. Chronic urticaria and IgA myeloma. Acta Derm Venereol 1998; 78: 395.
40. Karakelides M, Monson KL, Volcheck GW et al. Monoclonal gammopathies and malignancies in patients with chronic urticaria. Int J Dermatol 2006; 45: 1032-1038. (Pubitemid 44317114)
41. Lipsker D, Boeckler P. Cutaneous manifestations of paraproteinemia and their mechanisms. Presse Med 2007; 36: 1135-1140.
42. Jarošová K. Stillova choroba v dospělosti. Čes Revmatol 2006; 14: 159-163.
43. Gilson M, Abad S, Larroche C et al. Treatment of Schnitzler's syndrome with anakinra. Clin Exp Rheumatol 2007; 25: 931.
44. Glaser RL, Goldbach-Mansky R. The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies. Curr Allergy Asthma Rep 2008; 8: 288-298.
45. Padeh S. Periodic fever syndromes. Pediatr Clin North Am 2005; 52: 577-609. (Pubitemid 40463667)
46. Farasat S, Aksentijevich I, Toro JR. Autoinflammatory diseases: clinical and genetic advances. Arch Dermatol 2008; 144: 392-402. (Pubitemid 351439125)
47. Doutre MS, Beylot C. Chronic urticaria and monoclonal IgM: treatment with ibuprofen. J Am Acad Dermatol 1990; 22: 143-144. (Pubitemid 20035754)
48. Obořilová A, Adam Z. Schnitzler's syndrome. Vnitř Lék 1998; 44: 423-427.
49. Machet L, Vaillant L, Machet MC et al. Schnitzler's syndrome and associated with pseudoxanthoma elasticum. Acta Derm Venereol (Stockholm) 1991; 72: 22-24.
50. Lebbe C, Rybojad M, Klein F et al. Schnitzler's syndrome with sensorimotor neuropathy. J Am Acad Dermatol 1994; 30: 316-318.
51. de Koning HD, Bodar EJ, Simon A et al. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis 2006; 65: 542-544.
52. Schneider SW, Gaubitz M, Luger TA et al. Prompt response of refractory Schnitzler syndrome to treatment with anakinra. J Am Acad Dermatol 2007; 56 (Suppl 5): S120-S122. (Pubitemid 46552070)
53. Crouch R, Akhras V, Sarkany R. Schnitzler's syndrome: successful treatment with anakinra. Australas J Dermatol 2007; 48: 178-181. (Pubitemid 47197697)
54. Eiling E, Möller M, Kreiselmaier I et al. Schnizler syndrome: treatment failure to rituximab but response to anakinra. J Am Acad Dermatol 2007; 57: 361-364. (Pubitemid 47048871)
55. Klemmer N, Lenain P, Balguerie X et al. Effectiveness of anti-IL1 in Schnizler's syndrome. Jt Bone Spine 2007; 74: 509-510. (Pubitemid 47588969)
56. Thonhoffer R, Uitz E, Graninger W. Schnitzler's syndrome - exacerbation after anti-TNF treatment. Rheumatology 2007; 46: 1041-1042. (Pubitemid 47062523)
57. Eiling E, Schröder JO, Gross WL et al. The Schnitzler syndrome: chronic urticaria and monoclonal gammopathy - an autoinflammatory syndrome? J Dtsch Dermatol Ges 2008; 6: 626-631.
58. Devlin LA, Wright G, EdgarJD. A rare cause of a common symptom, Anakinra is effective in the urticaria of Schnitzler Syndrome: a case report. Cases J 2008; 1: 348.
59. Kluger N, Rivière S, Guillot B et al. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory Schnitzler's syndrome. Acta Derm Venereol 2008; 88: 287-288. (Pubitemid 351743881)
60. Frischmeyer-Guerrerio PA, Rachamalla R, Saini SS. Remission of Schnitzler syndrome after treatment with anakinra. Ann Allergy Asthma Immunol 2008; 100: 617-619. (Pubitemid 351829865)
61. Adam Z, Krejčí M, Pour L. Schnitzlerův syndrom - popis čtrnáctiletého průběhu nemoci a přehled informací o této nemoci. Vnitř Lék 2008; 54: 1140-1153.
62. Saiz E, Gálvez J, Mora A et al. Sindrome de Schnitzler y anakinra. Med Clin (Barc) 2008; 130: 357-358.
63. Lazarevic V, Markuszewska A, Stenberg B et al. Schnitzlers syndrome - okänt, sällsynt med behandlingsbart. Läkartidningen 2008; 105: 3348-3351.
64. Gallo R, Sabroe RA, Black AK et al. Schnitzler's syndrome: no evidence for autoimmune basis in two patients. Clin Exp Dermatol 2000; 25: 281-284. (Pubitemid 30670583)